INTRODUCTION
Bacteria that belong to the Burkholderia cepacia complex, originally described as plant pathogens by Burkholder (1950) , have now been recognized as major opportunistic pathogens of the respiratory tract in cystic fibrosis (CF) patients (Govan & Deretic, 1996; Mahenthiralingam et al., 2002) . Recent taxonomic studies have revealed that strains routinely identified as B. cepacia represent a complex of nine closely related species, all of which have been isolated from CF patients or the environment Vandamme et al., 2002) . These genomovars are very similar phenotypically, but show significant differences at the genomic level, allowing them to be considered as separate species. Next to B. cepacia (genomovar I), genomovars V and IX were also identified as genuine Burkholderia species, i.e. Burkholderia vietnamiensis (Gillis et al., 1995) and Burkholderia pyrrocinia (Vandamme et al., 1997) , respectively. Following the identification of distinguishing phenotypic biochemical characteristics and the development of novel molecular diagnostic tools, the names Burkholderia multivorans (Vandamme et al., 1997) , Burkholderia cenocepacia (Vandamme et al., 2003) , Burkholderia stabilis (Vandamme et al., 2000) , Burkholderia ambifaria (Coenye et al., 2001) and Burkholderia anthina were proposed for genomovars II, III, IV, VII and VIII, respectively. Genomovar VI has now been formally named 'Burkholderia dolosa' (Vermis et al., 2004) . Burkholderia ubonensis, a soil bacterium that was described by Yabuuchi et al. (2000) , may represent a tenth B. cepacia complex genomovar. B. multivorans and B. cenocepacia strains are known to be highly transmissible between CF patients .
It is important to develop sensitive laboratory diagnostic assays to better distinguish strains of the B. cepacia complex, in order to avoid misidentification of closely related bacteria. Several studies have presented different molecular methods for the detection and classification of these organisms, but these are not always sensitive enough to distinguish between the different B. cepacia genomovars. PCR-RFLP based on the 16S rRNA (Segonds et al., 1999; Vermis et al., 2002a) and recA (Mahenthiralingam et al., 2000a; McDowell et al., 2001; Vermis et al., 2002b) genes have been used to classify these organisms into genomovars. Although widely used for detection and classification, recent articles demonstrate that the 16S rRNA gene is limited in its ability to differentiate strains of the B. cepacia complex (LiPuma et al., 1999; Mahenthiralingam et al., 2000b; Vermis et al., 2002a) .
One particular class of outer-membrane proteins, the socalled peptidoglycan-associated lipoproteins (PALs), is conserved among many Gram-negative bacteria, such as Haemophilus influenzae (Deich et al., 1988; Nelson et al., 1988) , Escherichia coli (Chen & Henning, 1987) , Brucella abortus (Tibor et al., 1994) and Pseudomonas aeruginosa, where it is called OprL (Lim et al., 1997) . The exact function of PALs is unknown, but they have been shown to be necessary for resistance to detergents and antibiotics (Cascales et al., 2002) and for integrity of the cell envelope (Rodríguez-Herva et al., 1996) . Based on two outer-membrane lipoprotein genes, oprL and oprI, De Vos et al. (1997) developed a multiplex PCR assay for the specific detection and identification of P. aeruginosa in clinical specimens. Similarly, a real-time detection PCR, based on amplification of the oprL gene to detect and quantify P. aeruginosa in wound biopsy samples, was developed (Pirnay et al., 2000) .
In this article, we describe the cloning and molecular characterization of the opcL gene, which encodes the PAL from B. multivorans, and show that the corresponding gene can be amplified and used to detect and differentiate strains of the B. cepacia complex, including those from clinical specimens.
METHODS
Bacterial strains. Tables 1 and 2 list the 50 B. cepacia complex and other â-and ª-Proteobacteria reference strains and/or purified DNA, together with E. coli strains and plasmids, that were used in this study.
DNA preparation. DNA was prepared as described by Pitcher et al. (1989) .
Identification of the opcL gene of B. multivorans. A 400 bp fragment that contained the opcL gene of B. multivorans LMG 13010
T , but was missing 32 and 89 bp from the 59 and 39 ends of the ORF, respectively, was amplified by using primers that were derived from the opcL sequence of Burkholderia sp. LB 400, available from the US Department of Energy web site (www.jgi.doe.gov), with the following sequences: P33, 59-ATTGATGGTCGGTGCGCT-39, corresponding to position 33 of the gene, and P421R, 59-TCACGGCTTCTTC CATTTGCG-39, corresponding to position 421 of the opcL ORF.
Construction of a genomic library from B. multivorans. Genomic DNA from B. multivorans LMG 13010 T (20 ìg) was partially restricted with Sau3AI by using increasing dilutions of the restriction enzyme in a volume of 100 ìl. After 15 min, the reaction was stopped by addition of EDTA and 5 ìl aliquots from each tube were analysed by agarose gel electrophoresis. Fractions that contained fragments averaging 30 kb were pooled and their DNA was ligated to BamHI-restricted cosmid pRG930 (Van den Eede et al., 1992) . Packaging of ligated DNA and transformation of E. coli HB101 cells were done by using a GIGAPACK III kit, following the recommendations of the manufacturer (Stratagene). Colonies were selected on Luria-Bertani (LB) agar plates with streptomycin (25 ìg ml À1 ) and spectinomycin (50 ìg ml À1 ) and transferred with sterile toothpicks to individual wells of 96-well microtitre plates that each contained 100 ìl of the same medium. After incubation at 28 8C overnight, colonies were replicated by using an alcohol-and flame-sterilized replicator on agar plates. Plates were incubated overnight and an autoclave-sterilized nitrocellulose membrane (Hybond C, positively charged; Amersham) was laid on top and left for 1 h at room temperature. The membrane was first laid on a filter that was soaked in 1 % SDS to lyse the cells, and then on a filter that was soaked in denaturation solution (1 M NaOH, 1 . 5 M NaCl) for 15 min. After another 15 min incubation in neutralization solution (0 . 5 M Tris/HCl, 3 M NaCl; pH 7 . 5), DNA was cross-linked to the membrane after UV exposure. After pre-hybridization for 2 h at 42 8C, the membrane was hybridized overnight with a DIG-labelled (Roche) amplified opcL fragment. Chemiluminescent detection of positive clones was done by using the substrate CPD-star (Roche). One such clone was selected and sequenced by Genome Express (Paris, France) by using primers P04 (59-GAGTACAACCTAGCGCTG-39) and P04R (59-CCGAATAGCTGTC GAAGTC-39).
Cloning of the opcL gene from B. multivorans LMG 13010 T in expression vector pQE60. The B. multivorans LMG 13010 T opcL gene (without the start and stop codons) was PCR-amplified by using primers pONC1 (59-CATGCCATGGTGTCGAAAAAAGTTCGTCGT-39), which contained an NcoI restriction site and corresponded to the beginning of the ORF, and pOLBR500 (59-CGGGATCCCTGTTGG TAGACG-39), which contained a BamHI restriction site and corresponded to the end of the ORF. A fragment of 469 bp that contained the opcL gene was restricted with BamHI and NcoI and cloned into a pQE60 expression vector (Westburg). The resulting plasmid was transformed into E. coli M15 cells (which contained the pREP4 repressor plasmid) and colonies were selected on LB agar plates with ampicillin (100 ìg ml À1 ) and kanamycin (25 ìg ml À1 ).
Purification of the recombinant OpcL protein. The OpcL lipoprotein was purified with an Ni-NTA spin kit under denaturing conditions, following the recommendations of the manufacturer (Qiagen). Purity of OpcL was checked by SDS-PAGE followed by silver staining.
Obtainment of polyclonal antibodies against OpcL. BALB/c mice between 6 and 10 weeks old were immunized subcutaneously with 3 ìg purified OpcL protein that was emulsified in complete Freund's adjuvant. Second and third immunizations were done after 21 and 42 days, respectively, with the same amount of protein emulsified in incomplete Freund's adjuvant and without adjuvant, respectively. Blood samples were taken from the eye vein before the first immunization and 20 and 41 days after the second and third immunizations, respectively. Mice were killed after 63 days. Antibody specificity was checked against total membrane fractions of B. multivorans LMG 13010 T and E. coli M15 by Western blot.
Total extracts and outer membranes. Total and outer membranes were obtained from the bacterial pellet of a 50 ml culture by the Sarkosyl differential membrane solubilization method (Filip et al., 1973) as described previously (Cornelis et al., 1989; Lim et al., 1997) .
Immunofluorescence assays of bacterial cells. Cell pellets from B. multivorans LMG 13010 T , E. coli M15 and E. coli M15-opcL were obtained from 1 . 5 ml cultures that had been grown until they reached an OD 600 of 0 . 5 and then, when necessary, the cultures were induced for 3 h with IPTG. After washing with PBS, cells were incubated for 1 h with 1 % BSA (w/v) in PBS to block unspecific binding sites. Then, 500 ìl polyclonal anti-OpcL FITC-conjugate (1 : 1000) was allowed to react with the cells for 1 h, followed by three washing steps with PBS. After washing, each pellet was pre-equilibrated for 10 min in equilibration buffer from the SlowFade AntiFade kit (Molecular Probes). Following removal of equilibration buffer, 50 ìl component A and component B Table 2 . An aliquot (5 ìl) of the PCR mixture was subjected to electrophoresis in 1 % (w/v) agarose gel.
Amplification of opcL from sputa of CF patients. Sputum samples were collected, liquefied with mixing at room temperature for 20 min in an equal volume of Sputasol (Oxoid) and stored at À70 8C prior to DNA extraction. Liquefied sputum (300-500 ìl) was centrifuged at 13 000 g for 5 min. The supernatant was discarded and the pellet was resuspended in 500 ìl PBS. After repetition of the centrifugation step, DNA was isolated from the pellet by using a QIAamp DNA Mini kit (Qiagen), following the manufacturer's protocol for tissue. A 5 ìl aliquot of this DNA in a total reaction volume of 50 ìl was used directly in PCR assays, using an annealing temperature of 58 8C. The presence of bacterial DNA that was susceptible to PCR amplification was confirmed for each sample by PCR detection of 16S rRNA gene sequences by using the primer pair PSL and PSR, as described by Campbell et al. (1995) . Following purification by using Microspin S-400 HR columns (Amersham Biosciences), opcL PCR amplicons were sequenced directly (Lark Technologies, Saffron Walden, UK) by using the same primers that were employed in the PCR amplification (OLBam60 and OLKR511). As a further control, amplification of the cable pilin gene (cblA) was carried out, as described by Goldstein et al. (1995) .
DNA sequence and phylogenetic analysis. Amplified fragments (450 bp) that corresponded to the opcL gene were cloned into vector pCR2.1 (TA Cloning kit; Invitrogen) or into vector pUC19, restricted with SmaI. Sequencing was done for at least two clones from each genomovar by Eurogentec (Seraing, Belgium) by using universal primers. Multiple sequence alignments and a phylogenetic tree were constructed by using the BioNumerics 2.1 software package (Applied Maths), based on the neighbour-joining method (Saitou & Nei, 1987) .
RESULTS
Search for PAL homologues in Burkholderia sp. LB 400
The amino acid sequence from P. aeruginosa OprL was used in a BLAST comparison with translated Burkholderia sp. LB 400 genomic sequences; this was the only genome sequence that was available at the time this work was initiated (http:// www.jgi.doe.gov). One protein sequence gave 42 % similarity at the amino acid level, with a higher degree of similarity at the C-terminal end. The corresponding gene was named opcL. An amino acid alignment of OpcL from Burkholderia sp. LB 400 with other PALs revealed similarity levels that ranged from 36 to 66 % (Fig. 1) . Highest similarity (68 %) was to the PAL from Ralstonia metallidurans (http:// www.jgi.doe.gov). 
Amplification of the opcL gene of B. multivorans
Several primer pairs were designed, based on the opcL gene sequence of Burkholderia sp. LB 400, in order to amplify the opcL gene of B. multivorans LMG 13010
T . Of all primers tested, only P33 and P421 gave rise to the amplification of a single fragment with the expected size of 400 bp (data not shown). The identity of this fragment as opcL was confirmed by direct nucleotide sequence analysis of the PCR product. As the opcL fragment amplified from B. multivorans is incomplete (missing the 59 and 39 ends), a cosmid genomic library was prepared from B. multivorans in order to clone and sequence the complete opcL gene.
Screening of the B. multivorans genomic bank
Of 3000 clones in the cosmid genomic library from B. multivorans LMG 13010 T , three clones that hybridized with the 400 bp B. multivorans opcL fragment were selected. The complete opcL gene was further sequenced and its product was compared with those of other reported PALs by using the BioNumerics software program. These included the PALs from Burkholderia sp. LB 400 (http://www. jgi.doe.gov), P. aeruginosa (Lim et al., 1997) , E. coli (Chen & Henning, 1987) , H. influenzae (Nelson et al., 1988) , Pseudomonas putida (Rodríguez-Herva et al., 1996), R. metallidurans (http://www.jgi.doe.gov), Ralstonia solanacearum (http://www.jgi.doe.gov) and B. cenocepacia J2315 (http://www.sanger.ac.uk). The alignment between OpcL from B. multivorans, Burkholderia sp. LB 400 and B. cenocepacia revealed 82 and 95 % similarity, respectively. OpcL showed only 42 % similarity to OprL from P. aeruginosa (Fig. 1) .
Outer-membrane localization of OpcL
Production and outer-membrane localization of B. multivorans LMG 13010 T OpcL were demonstrated by SDS-PAGE and Western blot analyses. An 18 kDa protein band that corresponded to OpcL was clearly visible in the outermembrane preparations from B. multivorans LMG 13010 T and E. coli M15 pQE60-opcL, as detected by Western blot using a polyclonal anti-OpcL serum. No protein of the same molecular size could be detected from E. coli M15 on SDS-PAGE, nor on Western blot (Fig. 2a and b) .
Immunofluorescence assay
Immunofluorescence experiments were performed by using the mouse polyclonal antibody that was raised against the E. coli-produced and gel-purified OpcL. The polyclonal antibody M15-OpcL gave a positive reaction with E. coli M15 cells that were expressing opcL (Fig. 3b) , resulting in the staining of elongated cells that were also clearly observed in visible light (Fig. 3a) . No fluorescence was observed with E. coli M15 cells (Fig. 3d) ; furthermore, these cells had a normal appearance when observed in visible light (Fig. 3c) . No fluorescence was observed for B. multivorans LMG 13010 T cells without prior treatment with EDTA and SDS (results not shown).
PCR amplification of the opcL gene in B. cepacia complex strains
Based on the B. multivorans opcL sequence, we designed primers OLBam60 and OLKR511 to amplify the opcL gene (lacking the part that encodes the signal peptide sequence) from 50 different strains that belong to the B. cepacia complex. A fragment of 450 bp was amplified for all strains. Identity of the 450 bp fragment as opcL was subsequently confirmed by direct nucleotide sequence analysis of PCR products. No amplification product was detected for related species of â-proteobacteria, including Burkholderia species that do not belong to the B. cepacia complex (Table 2) .
Sequence comparison and phylogenetic analysis of the opcL gene opcL gene sequences from two to three strains in each genomovar were compared at the nucleotide level for the presence of substitutions, with the B. multivorans LMG 13010 T opcL sequence as reference. The 21 opcL sequences (corresponding to different genomovars) were extremely conserved, with 96 % nucleotide sequence similarity between B. cepacia complex strains. Construction of an opcL-based phylogenetic tree of the B. cepacia complex was carried out by using the B. multivorans LMG 13010
T opcL nucleotide sequence to root the tree. The resulting nucleotide sequence-based phylogenetic tree is shown in Fig. 4 .
Amplification of opcL from sputa of CF patients
The PCR assay that used the primer set OLBam60/OLKR511 was tested on sputum samples from 18 adult CF patients, all but three of whom were known to be colonized by B. cepacia complex strains. In accordance with colonization status, PCR amplicons were obtained from 15 of 18 samples. Sample PCR assay results are presented in Fig. 5 . The 15 amplicons were sequenced and, in each case, yielded unequivocal sequence data without the requirement for cloning the PCR product. Fourteen of the 15 sequences were identical and showed 100 % similarity to opcL from B. cenocepacia (results not shown). The same samples were also PCR-positive for the cblA gene, a marker for the B. cenocepacia ET12 lineage (Clode et al., 2000) . The other sequence was identified as B. multivorans, also with 100 % similarity.
DISCUSSION
Identification of Burkholderia strains by using opcL as a probe
The main goal of this study was to develop a rapid and sensitive additional method for specific detection and identification of B. cepacia complex strain isolates from natural and hospital environments. Early detection and accurate identification of B. cepacia complex strains are extremely important in the case of CF patients . Phenotypic identification techniques are often insufficiently reliable for the differentiation of strains within the B. cepacia complex. The API 20NE numerical identification system (bioMérieux) is considered to be the best system for biochemical identification of all B. cepacia complex strains except for B. stabilis and B. cepacia (Henry et al., 2001) . Discrimination could be improved if the API 20NE database were to incorporate negative p-nitrophenyl â-D-glucoside (PNPG) results and no growth at 4 8C as diagnostic criteria for B. stabilis (Henry et al., 2001) . B. multivorans, B. stabilis, B. vietnamiensis and genomovar VI were distinguished from other members of the B. cepacia complex by tests such as sucrose and adonitol acidification, PNPG utilization and growth at 42 8C (Henry et al., 2001) . Oxidation of sugars and oxidase reaction were also useful to distinguish Burkholderia gladioli, Ralstonia pickettii and Pandoraea spp. (Henry et al., 2001) .
Genomic analysis techniques proved to be more reliable tools for identification of B. gladioli, as demonstrated by speciesspecific PCR (SS-PCR) based on the 16S and 23S rRNA genes (Bauernfeind et al., 1998; Whitby et al., 2000) . By using PCR-RFLP of the 16S rRNA gene, Segonds et al. (1999) analysed 51 presumed B. cepacia clinical isolates, of which only 24 (47 %) were identified as B. cepacia and 15 (28 %) could not be identified completely. In the same study, one isolate was identified as Aeromonas salmonicida because of negative assimilation tests, and six of the 11 isolates that could not be identified by molecular tests were identified completely by use of the oxidase test.
Several groups have investigated SS-PCR and RFLP analysis as a tool to identify B. cepacia complex genomovars (Bauernfeind et al., 1998; LiPuma et al., 1999; Segonds et al., 1999; Whitby et al., 2000) . Reliable SS-PCR methods to identify B. multivorans and B. vietnamiensis, based on the 16S rRNA and 23S rRNA genes, have been described by LiPuma et al. (1999) . Sequence similarity of the 16S-23S rRNA genes among genomovars I, II and IV was, however, too high to allow the design of species-specific primers (LiPuma et al., 1999). Another SS-PCR based on recA has also been described (Vandamme et al., 2000; Mahenthiralingam et al., 2002) . Specificity and sensitivity of the recA-based PCR assay for 85 clinical and 17 environmental isolates of B. multivorans were both 100 % (Vermis et al., 2002b) . The same high specificity and sensitivity were obtained for B. ambifaria (six clinical and 47 environmental isolates), but the assay lacked sensitivity (72 %) in the case of B. cepacia genomovar I (29 clinical and 42 environmental isolates), which cross-reacted with all B. pyrrocinia isolates examined (Vermis et al., 2002b) .
Our analysis of opcL genes in strains of the B. cepacia complex demonstrated that it is a suitable additional marker for identification and classification of bacteria that belong to this complex group. Surprisingly, opcL was found to be extremely conserved within this apparently heterogeneous group, whereas 20 oprL alleles were found in P. aeruginosa alone (Pirnay et al., 2002) . In this regard, opcL can be considered, like oprI (which encodes another outer-membrane lipoprotein and is present in all pseudomonads), as being a 'genus' probe (De Vos et al., 1993 , 1997 , 1998 . Our study confirms that the conserved opcL gene encoding the PAL is a suitable additional marker for detection and identification of B. cepacia complex isolates and differentiation from other Burkholderia species that are not part of the complex, such as Burkholderia fungorum, Burkholderia graminis, Burkholderia terricola, B. gladioli and Burkholderia glumae. No amplification was obtained from other â-proteobacteria, such as Ralstonia, Bordetella, Pandoraea and Alcaligenes. Alignment of the opcL gene from the B. cepacia complex shows a low degree of nucleotide sequence variation (97 % similarity), whereas the gene product (the OpcL lipoprotein) is better opcL in the Burkholderia cepacia complex conserved, showing 98 % similarity. In the phylogenetic tree based on comparison of opcL sequences, B. multivorans LMG 13010 T clusters together with strains LMG 16668 and LMG 16660, with good bootstrap support between 83 and 100 % within the same genomovar. However, in this phylogenetic tree, not all strains that belong to the same genomovar cluster together.
In the tree based on sequence similarity of the opcL gene, strains of B. multivorans (genomovar II), B. stabilis (genomovar IV), 'B. dolosa' (genomovar VI), B. ambifaria (genomovar VII) and B. pyrrocinia (genomovar IX) clustered together, but the most defined clusters were observed for strains that belong to B. multivorans and B. ambifaria. Such easy differentiation of B. multivorans and B. ambifaria could be interesting, as Vandamme et al. (1997) showed that B. multivorans strains were mainly found in CF patients, whereas most of the highly transmissible strains were reported to be strictly specific to B. multivorans or B. cenocepacia (Segonds et al., 1999; Vandamme et al., 2003) .
Detection of Burkholderia strains from sputa
Although performed on a limited number of samples, we have demonstrated that amplicons can be generated from the sputa of patients who are known to be colonized by B. cepacia complex strains. Sequence analysis allowed unambiguous identification of strains and revealed that the majority of patients were colonized by B. cenocepacia (genomovar III), confirming the results of other studies Speert et al., 2002; Cunha et al., 2003) .
Expression of opcL and localization of the OpcL protein
The OpcL protein could be detected in the outer membranes of E. coli and Burkholderia spp. alike. Expression of the opcL gene in E. coli had an effect on the morphology of the cells; they appeared to be more elongated, an observation that is consistent with the results of another study where oprL from P. aeruginosa was expressed in E. coli (Lim et al., 1997) . The polyclonal antiserum that was raised against the denatured OpcL protein recognized epitopes that were exposed at the surface of the E. coli host, as shown by immunofluorescence experiments, but this was not the case when examining Burkholderia cells. Again, this situation is similar to that observed for oprL expression in E. coli and P. aeruginosa (Lim et al., 1997) .
We are now in the process of purifying OpcL from E. coli cells that express opcL, in order to use this antigen to detect the presence of antibodies in sputa of CF patients infected with Burkholderia spp.
Conclusion
This study shows that opcL is an interesting probe for the detection and identification of B. cepacia complex strains, either from colonies or in the sputa of CF patients.
